OsseoMatrix
Develops and manufactures patient-specific 3D-printed bioceramic bone implants for cranio-maxillo-facial and orthopedic reconstruction using a proprietary Direct Laser Microfusion (DLM) process.
- CEO / Founder
- Didier Nimal
- Team Size
- 11-50
- Stage
- Active
- Total Funding
- $6.9M
- Latest Round
- Grant
- Key Investors
- Texas Medical Center, Plug and Play Tech Center, MedTech Innovator, Finno Efra Accelerator
Technology & Products
Key Products
Custom bioceramic cranio-maxillo-facial implants; Patient-specific orthopedic bone loss implants; 3D surgical planning & implant design services
Technological Advantage
CLAIMED: Direct printing of pure ceramics eliminates debinding/sintering steps, reducing lead time and preserving material integrity. VERIFIED: Recognized by VoxelMatters as the only company commercially processing ceramics via selective laser melting/DLM. DEFENSIBLE: Proprietary process protected by patents and deep academic collaborations (CNRS, CEA, Ecole des Mines).
Differentiation
Value Proposition
Eliminates need for autologous bone grafts by providing custom, porous bioceramic implants that match patient CT scans, reducing surgical time, accelerating bone integration, and lowering long-term complication costs.
How They Differentiate
Unlike competitors using titanium, PEEK, or standard sintered ceramics, OsseoMatrix's DLM process prints pure bioceramics directly, achieving osteoconductive microporosity without post-processing. This reduces surgical time by enabling perfect anatomical fit and eliminates bone graft harvesting, lowering overall procedure costs and patient recovery time.
Market & Competition
Target Customers
Orthopedic and maxillofacial surgeons, hospitals, and medical device distributors
Industry Verticals
Medical Devices; Orthopedics; Maxillofacial Surgery; Dental Reconstruction
Competitors
Lithoz; 3D Systems; Materialise
Growth & Milestones
Growth Metrics
Founded as a deep-tech spin-off from the University of Paris-Saclay / ENS Paris-Saclay research laboratories.; Relocated to and established headquarters at the Paris-Saclay innovation ecosystem in Villebon-sur-Yvette, France.; Secured non-dilutive public funding and grants from Bpifrance (French Public Investment Bank) and regional Île-de-France innovation funds to scale their bioceramic 3D printing technology.
Major Milestones
2009: Founded by Dr. Didier Nimal; 2015: Winner of Concours Mondial d'Innovation Phase 2; 2016: Recognized among French 3D printing champions by Frenchweb; Commercialized proprietary Direct Laser Microfusion (DLM) process for bioceramics